Comparative Proteomic Analysis Reveals Metformin Improves the Expression of Biomarkers of Endometrial Receptivity in Infertile Women with Minimal/Mild Endometriosis

other OA: closed public-domain-us
Full text JSON View on PubMed View at publisher
AI-generated summary by claude@2026-07, 2026-07-16

Metformin treatment significantly upregulated endometrial receptivity biomarkers, particularly IGFBP-7, in infertile women with minimal/mild endometriosis compared to controls.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-07, 2026-07-16 · read from full text

This study investigated whether metformin changes endometrial receptivity in infertile women with laparoscopically diagnosed minimal/mild endometriosis by comparing paired secretory-phase endometrial tissues collected at surgery (baseline) and after 2 months of treatment with metformin (n=5) or no medical treatment (n=5). Using proteomics with a self-control design, the authors found six endometrial receptivity-associated proteins significantly upregulated after metformin (fold change >1.5, P<0.05), with IGFBP-7 showing the largest increase (fold change 8.668). IGFBP-7 upregulation was validated with target proteomics and immunohistochemistry, and was also demonstrated in autotransplantation-induced endometriosis mouse models. A key limitation is the small sample size (10 women total). This paper is centrally about endometriosis — it tests whether metformin improves eutopic endometrial receptivity in infertile women with minimal/mild endometriosis by upregulating IGFBP-7.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

The prevalence of endometriosis is approximately 10% in women of reproductive age, and 30-50% of women with endometriosis are infertile. Metformin has been reported to inhibit the growth of ectopic lesions in endometriosis. However, its effect on the eutopic endometrium of endometriosis is unknown. This study aimed to identify whether metformin affects endometrial receptivity in infertile women with minimal/mild endometriosis. We enrolled 10 infertile women who were diagnosed with minimal/mild endometriosis through laparoscopy. Paired endometrial tissues of the secretory phase from participants were collected during surgery and after 2 months of metformin treatment (n = 5) or no medical treatment (n = 5). Protein expression profiles of the paired endometrium were detected by proteomics and compared using the self-control method (2 months later vs. in surgery). Proteomics data revealed six proteins associated with endometrial receptivity among the significantly upregulated proteins after metformin treatment (fold change > 1.5, P < 0.05). Insulin-like growth factor binding protein 7 (IGFBP-7) showed the most robust increase in these six endometrial receptivity-related proteins (fold change: 8.668, P  0.05). The upregulation of IGFBP-7 has been validated through target proteomics, immunohistochemistry, and further demonstrated in endometriosis mouse models induced by autotransplantation. This study revealed that metformin upregulated the expression of IGFBP-7 in the endometrium of human and mouse models of endometriosis. Metformin potentially affects endometrial receptivity of minimal/mild endometriosis by improving the expression of the endometrial receptivity marker IGFBP-7.
Full text 15,638 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

The prevalence of endometriosis is approximately 10% in women of reproductive age, and 30–50% of women with endometriosis are infertile. Metformin has been reported to inhibit the growth of ectopic lesions in endometriosis. However, its effect on the eutopic endometrium of endometriosis is unknown. This study aimed to identify whether metformin affects endometrial receptivity in infertile women with minimal/mild endometriosis. We enrolled 10 infertile women who were diagnosed with minimal/mild endometriosis through laparoscopy. Paired endometrial tissues of the secretory phase from participants were collected during surgery and after 2 months of metformin treatment (n = 5) or no medical treatment (n = 5). Protein expression profiles of the paired endometrium were detected by proteomics and compared using the self-control method (2 months later vs. in surgery). Proteomics data revealed six proteins associated with endometrial receptivity among the significantly upregulated proteins after metformin treatment (fold change > 1.5, P < 0.05). Insulin-like growth factor binding protein 7 (IGFBP-7) showed the most robust increase in these six endometrial receptivity-related proteins (fold change: 8.668, P 0.05). The upregulation of IGFBP-7 has been validated through target proteomics, immunohistochemistry, and further demonstrated in endometriosis mouse models induced by autotransplantation. This study revealed that metformin upregulated the expression of IGFBP-7 in the endometrium of human and mouse models of endometriosis. Metformin potentially affects endometrial receptivity of minimal/mild endometriosis by improving the expression of the endometrial receptivity marker IGFBP-7. Similar content being viewed by others Availability of Data and Material The datasets generated and analyzed during the current study are available in the ProteomeXchange repository (accession number: PXD027648) [http://proteomecentral.proteomexchange.org/cgi/GetDataset]. Code Availability Not applicable. Change history 03 February 2022 A Correction to this paper has been published: https://doi.org/10.1007/s43032-022-00873-7

References

Dunselman GAJ, Vermeulen N, Becker C, Calhaz-Jorge C, D’Hooghe T, De Bie B, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29(3):400–12. https://doi.org/10.1093/humrep/det457. Marcoux S, Maheux R, Berube S, Langevin M, Graves G, Wrixon W, et al. Laparoscopic surgery in infertile, women with minimal or mild endometriosis. New Engl J Med. 1997;337(4):217–22. https://doi.org/10.1056/nejm199707243370401. Schenken RS, Guzick DS. Revised endometriosis classification: 1996. Fertil Steril. 1997;67(5):815–6. https://doi.org/10.1016/s0015-0282(97)81390-8. Khine YM, Taniguchi F, Harada T. Clinical management of endometriosis-associated infertility. Reprod Med Biol. 2016;15(4):217–25. https://doi.org/10.1007/s12522-016-0237-9. Craciunas L, Gallos I, Chu J, Bourne T, Quenby S, Brosens JJ, et al. Conventional and modern markers of endometrial receptivity: a systematic review and meta-analysis. Hum Reprod Update. 2019;25:202–23. https://doi.org/10.1093/humupd/dmy044. Yoshie M, Kusama K, Tanaka R, Okubo T, Kojima J, Takaesu Y, Isaka K, Nishi H, Tamura K. Possible roles of calreticulin in uterine decidualization and receptivity in rats and humans. Inter J Mol Sci. 2021;22(19). https://doi.org/10.3390/ijms221910505. Dominguez F, Avila S, Cervero A, Martin J, Pellicer A, Castrillo JL, et al. A combined approach for gene discovery identifies insulin-like growth factor-binding protein-related protein 1 as a new gene implicated in human endometrial receptivity. J Clin Endocrinol Metab. 2003;88(4):1849–57. https://doi.org/10.1210/jc.2002-020724. Liu ZK, Wang RC, Han BC, Yang Y, Peng JP. A novel role of IGFBP7 in mouse uterus: regulating uterine receptivity through Th1/Th2 lymphocyte balance and decidualization. PLoS ONE. 2012;7(9): e45224. https://doi.org/10.1371/journal.pone.0045224. Altmae S, Aghajanova L. What do we know about endometrial receptivity in women with endometriosis? Reprod Biomed Online. 2015;31(5):581–3. https://doi.org/10.1016/j.rbmo.2015.09.008. Lessey BA, Kim JJ. Endometrial receptivity in the eutopic endometrium of women with endometriosis—it is affected: let me show you why. Fertil Steril. 2017;108(1):19–27. https://doi.org/10.1016/j.fertnstert.2017.05.031. Ferrero S. Proteomics in the diagnosis of endometriosis: opportunities and challenges. Proteom Clin Appl. 2019;13(3). https://doi.org/10.1002/prca.201800183. Evans J, Hutchison J, Salamonsen LA, Greening DW. Proteomic insights into endometrial receptivity and embryo-endometrial epithelium interaction for implantation reveal critical determinants of fertility. Proteomics. 2020;20(1). https://doi.org/10.1002/pmic.201900250. Garrido-Gomez T, Quinonero A, Antunez O, Diaz-Gimeno P, Bellver J, Simon C, et al. Deciphering the proteomic signature of human endometrial receptivity. Hum Reprod. 2014;29(9):1957–67. https://doi.org/10.1093/humrep/deu171. Zhang X, Liu D, Huang W, Wang Q, Feng X, Tan J. Prediction of endometriosis fertility index in patients with endometriosis-associated infertility after laparoscopic treatment. Reprod BioMedicine Online. 2018;37(1):53–9. https://doi.org/10.1016/j.rbmo.2018.03.012. Tanbo T, Fedorcsak P. Endometriosis-associated infertility: aspects of pathophysiological mechanisms and treatment options. Acta Obstet Gyn Scan. 2017;96(6):659–67. https://doi.org/10.1111/aogs.13082. Ferrero S, Remorgida V, Venturini PL. Pharmacotherapy for endometriosis. Expert Opin Pharmaco. 2010;11(7):1123–34. https://doi.org/10.1517/14656561003685880. de Ziegler D, Pirtea P, Poulain M, Carbonel M, Even M, Ayoubi JM. Toxic pelvic cavity in endometriosis, a new frontier for medical therapies. Fertil Steril. 2018;110(4):644–5. https://doi.org/10.1016/j.fertnstert.2018.05.018. Morin-Papunen L, Rantala AS, Unkila-Kallio L, Tiitinen A, Hippelainen M, Perheentupa A, et al. Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): a multicenter, double-blind, placebo-controlled randomized trial. J Clin Endocrinol Metab. 2012;97(5):1492–500. https://doi.org/10.1210/jc.2011-3061. Zhai J, Yao GD, Wang JY, Yang QL, Wu L, Chang ZY, et al. Metformin regulates key microRNAs to improve endometrial receptivity through increasing implantation marker gene expression in patients with PCOS undergoing IVF/ICSI. Reprod Sci. 2019;26(11):1439–48. https://doi.org/10.1177/1933719118820466. Mohsen IA, Elkattan E, Nabil H, Khattab S. Effect of metformin treatment on endometrial vascular indices in anovulatory obese/overweight women with polycystic ovarian syndrome using three-dimensional power doppler ultrasonography. J Clin Ultrasound. 2013;41(5):275–82. https://doi.org/10.1002/jcu.22006. Zhou Y, Xu JN, Zeng C, Li X, Zhou YF, Qi Y, et al. Metformin suppresses prostaglandin E2-induced cytochrome P450 aromatase gene expression and activity via stimulation of AMP-activated protein kinase in human endometriotic stromal cells. Reprod Sci. 2015;22(9):1162–70. https://doi.org/10.1177/1933719115590664. Zhang H, Xue J, Li M, Zhao X, Wei D, Li C. Metformin regulates stromal-epithelial cells communication via Wnt2/beta-catenin signaling in endometriosis. Mol Cell Endocrinol. 2015;413(C):61–5. https://doi.org/10.1016/j.mce.2015.06.011. Xu JN, Zeng C, Zhou Y, Peng C, Zhou YF, Xue Q. Metformin inhibits StAR expression in human endometriotic stromal cells via AMPK-mediated disruption of CREB-CRTC2 complex formation. J Clin Endocrinol Metab. 2014;99(8):2795–803. https://doi.org/10.1210/jc.2014-1593. Yilmaz B, Sucak A, Kilic S, Aksakal O, Aksoy Y, Lortlar N, et al. Metformin regresses endometriotic implants in rats by improving implant levels of superoxide dismutase, vascular endothelial growth factor, tissue inhibitor of metalloproteinase-2, and matrix metalloproteinase-9. Am J of Obstet Gynecol. 2010;202(4):202. https://doi.org/10.1016/j.ajog.2009.10.873. Oner G, Ozcelik B, Ozgun MT, Serin IS, Ozturk F, Basbug M. The effects of metformin and letrozole on endometriosis and comparison of the two treatment agents in a rat model. Hum Reprod. 2010;25(4):932–7. https://doi.org/10.1093/humrep/deq016. Foda AA, Aal IA A. Metformin as a new therapy for endometriosis, its effects on both clinical picture and cytokines profile. Middle East Fertil Soc J. 2012;17(4):262–7. https://doi.org/10.1016/j.mefs.2012.09.001. Med PCASR. Fertility evaluation of infertile women: a committee opinion. Fertil Steril. 2021;116:1255–65. https://doi.org/10.1016/j.fertnstert.2021.08.038. Rhee JS, Saben JL, Mayer AL, Schulte MB, Asghar Z, Stephens C, et al. Diet-induced obesity impairs endometrial stromal cell decidualization: a potential role for impaired autophagy. Hum Reprod. 2016;31(6):1315–26. https://doi.org/10.1093/humrep/dew048. MacLean B, Tomazela DM, Shulman N, Chambers M, Finney GL, Frewen B, et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics. 2010;26(7):966–8. https://doi.org/10.1093/bioinformatics/btq054. Huffman RG, Chen A, Specht H, Slavov N. DO-MS: Data-driven optimization of mass spectrometry methods. J Proteome Res. 2019;18(6):2493–500. https://doi.org/10.1021/acs.jproteome.9b00039. Bruderer R, Bernhardt OM, Gandhi T, Miladinovic SM, Cheng L-Y, Messner S, et al. Extending the limits of quantitative proteome profiling with data-independent acquisition and application to acetaminophen- treated three-dimensional liver microtissues. Mol Cell Proteomics. 2015;14(5):1400–10. https://doi.org/10.1074/mcp.M114.044305. Thakur Z, Dharra R, Saini V, Kumar A, Mehta PK. Insights from the protein-protein interaction network analysis of Mycobacterium tuberculosis toxin-antitoxin systems. Bioinformation. 2017;13(11):380–7. https://doi.org/10.6026/97320630013380. Kutsukake M, Tamura K, Yoshie M, Tachikawa E. Knockdown of IGF-binding protein 7 inhibits transformation of the endometrial gland in an in vitro model. Mol Reprod Dev. 2010;77(3):265–72. https://doi.org/10.1002/mrd.21143. Parmar T, Gadkar-Sable S, Savardekar L, Katkam R, Dharma S, Meherji P, Puri CP, Sachdeva G. Protein profiling of human endometrial tissues in the midsecretory and proliferative phases of the menstrual cycle. Fertil Steril. 2009;92(3):1091–103. https://doi.org/10.1016/j.fertnstert.2008.07.1734. Germeyer A, Capp E, Schlicksupp F, Jauckus J, von Rango U, von Wolff M, et al. Cell-type specific expression and regulation of apolipoprotein D and E in human endometrium. Eur J Obstet Gyn R B. 2013;170(2):487–91. https://doi.org/10.1016/j.ejogrb.2013.06.043. Chen JIC, Hannan NJ, Mak Y, Nicholls PK, Zhang J, Rainczuk A, et al. Proteomic characterization of midproliferative and midsecretory human endometrium. J Proteome Res. 2009;8(4):2032–44. https://doi.org/10.1021/pr801024g. Li J, Tan Z, Li M, Xia T, Liu P, Yu W. Proteomic analysis of endometrium in fertile women during the prereceptive and receptive phases after luteinizing hormone surge. Fertil Steril. 2011;95(3):1161–3. https://doi.org/10.1016/j.fertnstert.2010.09.033. Azkargorta M, Escobes I, Iloro I, Osinalde N, Corral B, Ibanez-Perez J, et al. Differential proteomic analysis of endometrial fluid suggests increased inflammation and impaired glucose metabolism in non-implantative IVF cycles and pinpoints PYGB as a putative implantation marker. Hum Reprod. 2018;33(10):1898–906. https://doi.org/10.1093/humrep/dey274. Laskov I, Drudi L, Beauchamp M-C, Yasmeen A, Ferenczy A, Pollak M, Gotlieb WH. Anti-diabetic doses of metformin decrease proliferation markers in tumors of patients with endometrial cancer. Gynecol Oncol. 2014;134(3):607–14. https://doi.org/10.1016/j.ygyno.2014.06.014. Xia C, Yang F, He Z, Cai Y. iTRAQ-based quantitative proteomic analysis of the inhibition of cervical cancer cell invasion and migration by metformin. Biomed Pharmacother 2020;123. https://doi.org/10.1016/j.biopha.2019.109762. Komiya E, Sato H, Watanabe N, Ise M, Higashi S, Miyagi Y, Miyazaki K. Angiomodulin, a marker of cancer vasculature, is upregulated by vascular endothelial growth factor and increases vascular permeability as a ligand of integrin αvβ3. Cancer Med. 2014;3(3):537–49. https://doi.org/10.1002/cam4.216. Altmäe S, Esteban FJ, Stavreus-Evers A, Simon C, Giudice L, Lessey BA, Horcajadas JA, Macklon NS, D'Hooghe T, Campoy C, Fauser BC, Salamonsen LA, Salumets A. Guidelines for the design, analysis and interpretation of ‘omics’ data: focus on human endometrium. Hum Reprod Update. 2014;20(1):12–28. https://doi.org/10.1093/humupd/dmt048. Zhou JT, Liu HY, Liu Y, Liu J, Zhao XY, Yin YX. Development and Evaluation of a Parallel Reaction Monitoring Strategy for Large-Scale Targeted Metabolomics Quantification. Anal Chem. 2016;88(8):4478–86. https://doi.org/10.1021/acs.analchem.6b00355. Gillet LC. Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol Cell Proteomics. 2012; 11(6). https://doi.org/10.1074/mcp.O111.016717 Rauniyar N. Parallel reaction monitoring: a targeted experiment performed using high resolution and high mass accuracy mass spectrometry. Inter J Mol Sci. 2015;16(12):28566–81. https://doi.org/10.3390/ijms16122612. Abkenari SA, Safdarian L, Amidi F, Hosseini A, Aryanpour R, Salahi E, et al. Metformin improves epigenetic modification involved in oocyte growth and embryo development in polycystic ovary syndrome mice model. Mol Reprod Dev. 2021(online). https://doi.org/10.1002/mrd.23537 Huang Y, Yu Y, Gao J, Li R, Zhang C, Zhao H, et al. Impaired oocyte quality induced by dehydroepiandrosterone is partially rescued by metformin treatment. Plos One 2015;10(3): e0122370. https://doi.org/10.1371/journal.pone.012237 Funding This study was funded by the National Key R&D Program of China (Grant number: 2017YCF1001200), Fundamental Research Funds for the Central Universities (SCU2019C4198), and International Science and Technology Cooperation Project of Chengdu (2017-GH02-000060-HZ). Author information Authors and Affiliations Contributions XH implemented human research and analyzed data, drafted the manuscript; LX designed the research and revised the manuscript; YL performed animal experiments and analyzed data; TP assisted with experiments and revised the manuscript, BL, TL, and YL collected and prepared samples; HZ and YO made the concept and supervised the research; WH designed the research, revised the manuscript, and approved the final vision. Corresponding author Ethics declarations Ethics Approval The study was approved by the Ethics Committee of Sichuan University (Grant number: K2017042-1 and K2017042-2). Consent to Participate Written informed consents were obtained from all participants. Consent for Publication Not applicable. Competing Interests The authors declare no competing interests. Additional information This article was updated to include the article note: Xin Huang, Li Xiao and Ying Long have contributed equally to this work and share first authorship. Rights and permissions About this article Cite this article Huang, X., Xiao, L., Long, Y. et al. Comparative Proteomic Analysis Reveals Metformin Improves the Expression of Biomarkers of Endometrial Receptivity in Infertile Women with Minimal/Mild Endometriosis. Reprod. Sci. 29, 2593–2606 (2022). https://doi.org/10.1007/s43032-022-00869-3 Received: Accepted: Published: Version of record: Issue date: DOI: https://doi.org/10.1007/s43032-022-00869-3

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Endometriosis Endometriosis Endometriosis Endometriosis Infertility, Female Infertility, Female Metformin Metformin Adult Animals Biomarkers Biomarkers Endometrium Endometrium Female Humans Mice Proteomics

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-08-08T06:08:32.324769+00:00
pubmed
last seen: 2026-05-13T22:24:03.506079+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine